PHOENIX, April 17, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today confirmed the expanding deployment of EvolveTM Rat Birth Control in the Wicker Park Bucktown Special Service Area of Chicago. The new program from the Wicker Park Bucktown Chamber of Commerce has crews installing bait boxes with Evolve Rat in alleys behind several major thoroughfares in the neighborhoods. The goal, according to Alice Howe, Special Service Area N. 33 Program Manager, is to control the rat population without the t

PHOENIX, March 31, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a pioneer in fertility control solutions for managing rodent populations, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2025 Industrials & Basic Materials Investor Summit, taking place virtually on Tuesday, April 1, 2025. The fireside chat will take place at 3:00 p.m. ET on Tuesday, April 1, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/ibmsummit25/ or directly at https:/

Company announces new operating optimization initiatives to reduce expenses by approximately $2 million to accelerate path to profitability PHOENIX, March 12, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a pioneer in fertility control solutions for managing rodent populations, today announced fourth quarter and full year 2024 financial results. Q4 2024 Highlights Revenue increased 70% to $501,000 in Q4 2024 compared to $295,000 in Q4 2023, led by growth in e-commerce which increased 206%.Gross profit margin percentage improved to 60

PHOENIX, March 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a pioneer in fertility control solutions for managing rodent populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 374,718 shares of the Company's common stock originally issued by the Company on August 23, 2024, each having an original exercise price of $4.35 per share, at a reduced exercise price of $2.90 per share. In addition, the Company will issue new short-term warrants, as described below. The closing of the warrant exercise transaction is expected to occur on or about March 11,

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, March 6, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its fourth quarter and fiscal year 2024, ended December 31, 2024, after the market close on Wednesday, March 12, 2025. The Company has scheduled a conference call that same day, Wednesday, March 12, 2025, at 5:00 pm ET, to review the results. Fourth Quarter and Fiscal Year 2024 Conference Call Details Date and Time: Wednesday, March 12, 2025, at 5:00 pm ET Call-in Information: I

SenesTech and Distribution Partner to Bring Evolve™ to New Zealand's Predator Free 2050 Initiative PHOENIX, Feb. 25, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, is pleased to announce a significant milestone in its expansion into vast and largely untapped markets for rodent fertility control across New Zealand and Australia. In partnership with Evicom, a provider of environmental consulting, on-ground environmental management and wildlife control and management services across Australia and New Zealand, SenesTech is bringing Evolve™ Rat and Evolve™ Mouse to the forefront of integrated pest management (IPM) solu

PHOENIX, Ariz., Feb. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", )), a pioneer in humane rodent pest control solutions, is pleased to announce the shipment of a substantial order of its Evolve™ Rodent Birth Control product to one of the largest warehousing and distribution companies in the Midwest. This marks SenesTech's entry into the warehousing and distribution sector, with the unnamed customer planning to implement Evolve Rodent Birth Control™ within their own facilities and distribute it through their extensive network. The warehousing industry i

PHOENIX, Feb. 10, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", )), a pioneer in humane rodent pest control solutions, is pleased to announce that its Evolve™ Rodent Birth Control product line is now available for purchase on TractorSupply.com. This expansion represents another key milestone in SenesTech's e-commerce growth strategy, bringing its innovative and effective rodent control solution to a broader customer base nationwide. Tractor Supply Company is the largest rural lifestyle retailer in the United States, operating over 2,200 stores across 49 sta

PHOENIX, Feb. 4, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in humane pest control solutions, is pleased to announce its plans to enter the Indian rodent pest control market through a partnership with SMark, a well-established distributor based in India. The partnership is cemented by a recently signed letter of intent, underscoring the shared commitment to bringing innovative, non-lethal rodent control solutions to this rapidly growing market. India presents a significant opportunity for rodent pest control solutions, with an estimated market size exceeding

Identifies Population Control as a Humane, Effective Solution for Winning the War Against Rats PHOENIX, Jan. 21, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in innovative pest control solutions, is pleased to announce that the City of Baltimore has begun integrating Evolve™, SenesTech's cutting-edge rodent birth control product, into the city's rodent management programs. This marks a pivotal step in Baltimore's efforts to address its significant rodent population, a challenge highlighted by a recent ranking of Baltimore as one of America's "rattiest cities." The city has placed a substantial initial order for Evolve and plans to deploy the product this quarter as part of it

424B5 - SenesTech, Inc. (0001680378) (Filer)

PRE 14A - SenesTech, Inc. (0001680378) (Filer)

D - SenesTech, Inc. (0001680378) (Filer)

8-K - SenesTech, Inc. (0001680378) (Filer)

8-K - SenesTech, Inc. (0001680378) (Filer)

SCHEDULE 13G/A - SenesTech, Inc. (0001680378) (Subject)

8-K - SenesTech, Inc. (0001680378) (Filer)

10-Q - SenesTech, Inc. (0001680378) (Filer)

8-K - SenesTech, Inc. (0001680378) (Filer)

EFFECT - SenesTech, Inc. (0001680378) (Filer)

PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

PHOENIX, Nov. 14, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the appointment of Joel Fruendt as SenesTech's new Chief Executive Officer, succeeding Ken Siegel. Mr. Siegel, who is expected to retire at the end of the year, will remain as an Executive Director, in a consultative role, through the transition period. This leadership transition is part of SenesTech's ongoing strategic plan to drive the commercialization of ContraPest, its flagship product.

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G - SenesTech, Inc. (0001680378) (Subject)

SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

4 - SenesTech, Inc. (0001680378) (Issuer)

3 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

4 - SenesTech, Inc. (0001680378) (Issuer)

Company announces new operating optimization initiatives to reduce expenses by approximately $2 million to accelerate path to profitability PHOENIX, March 12, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a pioneer in fertility control solutions for managing rodent populations, today announced fourth quarter and full year 2024 financial results. Q4 2024 Highlights Revenue increased 70% to $501,000 in Q4 2024 compared to $295,000 in Q4 2023, led by growth in e-commerce which increased 206%.Gross profit margin percentage improved to 60

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, March 6, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its fourth quarter and fiscal year 2024, ended December 31, 2024, after the market close on Wednesday, March 12, 2025. The Company has scheduled a conference call that same day, Wednesday, March 12, 2025, at 5:00 pm ET, to review the results. Fourth Quarter and Fiscal Year 2024 Conference Call Details Date and Time: Wednesday, March 12, 2025, at 5:00 pm ET Call-in Information: I

Record Revenue and Margin Performance PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Revenues of $1.4 million in the first nine months of 2024, an increase of 51% compared to the same period of 2023.Gross margin percentages improved to 65% during Q3 2024 compared to

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results. Third Quarter 2024 Conference Call Details Date and Time: Tuesday, November 12, 2024, at 5:00 pm ET Call-in Information: Interested parties can access th

Record Revenue and Margin Performance PHOENIX, Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. Recent Highlights Record revenues of $874,000 in the first half of 2024, an increase of 62% compared to the first half of 2023.Gross margin percentages improved to 54% during Q2 2024 compared to 47% in Q1 2024

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 1, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on Thursday, August 8, 2024. The Company has scheduled a conference call that same day, Thursday, August 8, 2024, at 5:00 pm ET, to review the results. Second Quarter 2024 Conference Call Details Date and Time: Thursday, August 8, 2024, at 5:00 pm ET Call-in Information: Interested parties can access the confere

PHOENIX, May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024. Recent Highlights Record quarterly revenues during Q1 2024 of $415,000, an increase of 78% compared to Q1 2023.Evolve™, formulated especially for the control of rat fertility and launched at the beginning of the year, has quickly become the Company'

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 2, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its first quarter 2024, ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company has scheduled a conference call that same day, Thursday, May 9, 2024, at 5:00 pm ET, to review the results. First Quarter 2024 Conference Call Details Date and Time: Thursday, May 9, 2024, at 5:00 pm ET Call-in Information: Interested parties can access the conference call by

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Feb. 15, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its fourth quarter and fiscal year 2023, ended December 31, 2023, after the market close on Wednesday, February 21, 2024. The Company has scheduled a conference call that same day, Wednesday, February 21, 2024, at 5:00 pm ET, to review the results. Fourth Quarter and Fiscal Year 2023 Conference Call Details Date and Time: Wednesday, February 21, 2024, at 5:00 pm ET Call-in Infor

July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX, Aug. 10, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced financial results for the second quarter of 2023 for the period ended June 30, 2023. "We successfully executed against a number of key strategic imperatives to drive long-term growth in Co